MYO6 and gastric cancer: A prior study revealed that concurrent overexpression of miR-145-5p and miR-143-3p, a member of the miR-145-5p family, synergistically suppressed MYO6 expression in gastric cancer, exhibiting greater inhibitory effects than miR-145-5p alone [57].